Paradigm Medical Industries, Inc. (PDMI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2011 | 2.16 Million USD | -12.15% |
| 2010 | 2.46 Million USD | -19.52% |
| 2009 | 3.05 Million USD | -20.09% |
| 2008 | 3.82 Million USD | 40.8% |
| 2007 | 2.71 Million USD | 10.98% |
| 2006 | 2.44 Million USD | 23.31% |
| 2005 | 1.98 Million USD | 2937.14% |
| 2004 | -70 Thousand USD | -366.67% |
| 2003 | -15 Thousand USD | 78.57% |
| 2002 | -70 Thousand USD | 97.22% |
| 2001 | -2.51 Million USD | -16.51% |
| 2000 | -2.16 Million USD | -116.2% |
| 1999 | -1 Million USD | -900.0% |
| 1998 | -100 Thousand USD | -150.0% |
| 1997 | 200 Thousand USD | 106.67% |
| 1996 | -3 Million USD | -900.0% |
| 1995 | -300 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2011 FY | 2.16 Million USD | -12.15% |
| 2010 FY | 2.46 Million USD | -19.52% |
| 2009 FY | 3.05 Million USD | -20.09% |
| 2009 Q1 | 1.89 Million USD | -50.41% |
| 2008 Q2 | 3.33 Million USD | 7.27% |
| 2008 Q3 | 3.72 Million USD | 11.79% |
| 2008 Q4 | 3.82 Million USD | 2.71% |
| 2008 Q1 | 3.1 Million USD | 14.31% |
| 2008 FY | 3.82 Million USD | 40.8% |
| 2007 Q3 | 3.32 Million USD | 7.19% |
| 2007 Q1 | 2.58 Million USD | 5.63% |
| 2007 Q2 | 3.1 Million USD | 19.95% |
| 2007 Q4 | 2.71 Million USD | -18.28% |
| 2007 FY | 2.71 Million USD | 10.98% |
| 2006 FY | 2.44 Million USD | 23.31% |
| 2006 Q1 | 1.94 Million USD | -1.91% |
| 2006 Q2 | 2.08 Million USD | 6.78% |
| 2006 Q4 | 2.44 Million USD | 2.34% |
| 2006 Q3 | 2.39 Million USD | 15.05% |
| 2005 Q3 | 1.91 Million USD | 32.53% |
| 2005 FY | 1.98 Million USD | 2937.14% |
| 2005 Q1 | -23 Thousand USD | 67.14% |
| 2005 Q2 | 1.44 Million USD | 6382.61% |
| 2005 Q4 | 1.98 Million USD | 3.71% |
| 2004 Q2 | -12 Thousand USD | -400.0% |
| 2004 FY | -70 Thousand USD | -366.67% |
| 2004 Q4 | -70 Thousand USD | 38.05% |
| 2004 Q1 | 4000.00 USD | 126.67% |
| 2004 Q3 | -113 Thousand USD | -841.67% |
| 2003 Q4 | -15 Thousand USD | 25.0% |
| 2003 FY | -15 Thousand USD | 78.57% |
| 2003 Q3 | -20 Thousand USD | 95.88% |
| 2003 Q1 | 17 Thousand USD | 124.29% |
| 2003 Q2 | -486 Thousand USD | -2958.82% |
| 2002 FY | -70 Thousand USD | 97.22% |
| 2002 Q4 | -70 Thousand USD | 79.83% |
| 2002 Q3 | -347 Thousand USD | 16.99% |
| 2002 Q2 | -418 Thousand USD | 57.13% |
| 2002 Q1 | -975 Thousand USD | 61.29% |
| 2001 Q1 | -983 Thousand USD | 54.53% |
| 2001 FY | -2.51 Million USD | -16.51% |
| 2001 Q4 | -2.51 Million USD | -19.61% |
| 2001 Q3 | -2.1 Million USD | 27.75% |
| 2001 Q2 | -2.91 Million USD | -196.54% |
| 2000 Q2 | -2.73 Million USD | 16.17% |
| 2000 Q3 | -3.15 Million USD | -15.09% |
| 2000 Q4 | -2.16 Million USD | 31.37% |
| 2000 Q1 | -3.26 Million USD | -226.5% |
| 2000 FY | -2.16 Million USD | -116.2% |
| 1999 Q3 | -200 Thousand USD | 66.67% |
| 1999 Q4 | -1 Million USD | -400.0% |
| 1999 FY | -1 Million USD | -900.0% |
| 1999 Q1 | -1 Million USD | -900.0% |
| 1999 Q2 | -600 Thousand USD | 40.0% |
| 1998 Q2 | -1.2 Million USD | 33.33% |
| 1998 Q1 | -1.8 Million USD | -1000.0% |
| 1998 FY | -100 Thousand USD | -150.0% |
| 1998 Q4 | -100 Thousand USD | 85.71% |
| 1998 Q3 | -700 Thousand USD | 41.67% |
| 1997 Q4 | 200 Thousand USD | 150.0% |
| 1997 Q2 | 500 Thousand USD | 129.41% |
| 1997 FY | 200 Thousand USD | 106.67% |
| 1997 Q3 | -400 Thousand USD | -180.0% |
| 1997 Q1 | -1.7 Million USD | 32.0% |
| 1996 Q3 | -3 Million USD | -850.0% |
| 1996 Q2 | 400 Thousand USD | 0.0% |
| 1996 FY | -3 Million USD | -900.0% |
| 1996 Q4 | -2.5 Million USD | 16.67% |
| 1995 FY | -300 Thousand USD | 0.0% |
| 1995 Q3 | -300 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | -350.763% |
| Ansell Limited | -54.99 Million USD | 103.931% |
| Ansell Limited | -55.1 Million USD | 103.924% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | -36.49 Million USD | 105.924% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | 2157.049% |
| Psykey, Inc. | 634.59 Thousand USD | -240.691% |
| ConvaTec Group Plc | 1.2 Billion USD | 99.82% |
| ConvaTec Group Plc | 1.2 Billion USD | 99.82% |
| Encision Inc. | 1.29 Million USD | -67.507% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | 6.355% |
| Innovative MedTech Inc. | 1.76 Million USD | -22.511% |
| LifePoint, Inc. | -3.26 Million USD | 166.237% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | 55.915% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | 5092.61% |
| Reflect Scientific, Inc. | -1.03 Million USD | 308.827% |
| SmileDirectClub, Inc. | 778.67 Million USD | 99.722% |
| Sector 10, Inc. | 163 Thousand USD | -1226.38% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 100.518% |
| SheerVision, Inc. | 57.34 Thousand USD | -3669.9% |
| United Health Products, Inc. | 660.56 Thousand USD | -227.294% |
| Vasamed, Inc. | 22.12 Thousand USD | -9673.077% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | 17.833% |
| Yubo International Biotech Limited | 772.27 Thousand USD | -179.951% |